S&P 500
5,933.08
-0.1%
-7.38
DJI
42,363.01
-0.7%
-314.23
NASDAQ
$19,207.91
+0.3%
+$65.19
Bitcoin
109,064.00
+4.0%
+4,243.45
AAPL
$206.97
+0.1%
+$0.11
AMZN
$203.15
-0.5%
-$0.92
GOOG
$173.83
+5.1%
+$8.51
META
$645.07
+1.3%
+$7.97
MSFT
$457.13
-0.2%
-$1.04
NVDA
$135.95
+1.2%
+$1.57
TSLA
$345.50
+0.5%
+$1.68
Genetic Technologies (NASDAQ: GENE)
Some price data may be temporarily unavailable.
Genetic Technologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Genetic Technologies Company Info
Genetic Technologies Ltd. is a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The GeneType/Corporate segment includes tha GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
News & Analysis
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.